Expression of a peroral
infection factor determines pathogenicity and population structure in an insect virus.
In this paper, we have modified a PBPK model for peroral
exposure to BPA developed by Yang et al.
Lure vaccine-containing antirabies for peroral
immunization of wild carnivores 3 000 doses, indicated by participants
He is one of only a few physicians worldwide who can perform a peroral
endoscopic myotomy (POEM), a technique that helps patients with swallowing disorders.
Yap et al., "IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral
infection with Toxoplasma gondii," Journal of Immunology, vol.
Medical treatment of these inoperable patients and the patients with palliative surgery included diazoxide (n = 4), somatostatin analogues (n = 5), radiation therapy of metastases (n = 2), 5-fluorouracilstreptozotocin (n = 3), sunitinib (n = 1), doxorubicin (n = 1), doxorubicin-dacarbazine (n =1), interferon alpha (n = 3), peroral
corticosteroids (n = 4), dearterialization and embolization of liver arteries (n = 1), chemoembolization of liver metastases (n =1), resection and thermoablation of liver metastases (n =1), and superselective embolization of a branch of the gastroduodenal artery (n =1).
A recent innovation of the endoscopic submucosal tunnelling technique is gastric peroral
endoscopic myotomy (G-POEM).
Period Therapy Dosage and reasons of dosage changes Diagnosis (2004), Danazol peroral
50-200 mg/day 2013 (according to the patient's symptoms) 2013-2014 (in vitro IV (intravenous) 1000 U/twice a week fertilization pdC1INH (LHRH injections were therapies) repeated four times.
The day after surgical removal of the foreign body, the intravenous cefuroxime was discontinued, and he was prescribed a 10-day course of ciprofloxacin (750 mg three times a day) peroral
The BRAF inhibitor vemurafenib at a classical dose of 960 mg twice per day peroral
with a combination of infusional panitumumab 6 mg/kg biweekly was chosen for the patient according to the early results of currently ongoing clinical studies of vemurafenib in BRAF V600E mutated CRCs.
Junginger, "Niosomes as a novel peroral
vaccine delivery system," International Journal of Pharmaceutics, vol.
Panchagnula, "In situ and in vivo efficacy of peroral
absorption enhancers in rats and correlation to in vitro mechanistic studies," Farmaco, vol.